343 related articles for article (PubMed ID: 8464868)
1. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.
Saito K; Elce JS; Hamos JE; Nixon RA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2628-32. PubMed ID: 8464868
[TBL] [Abstract][Full Text] [Related]
2. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease.
Nixon RA; Saito KI; Grynspan F; Griffin WR; Katayama S; Honda T; Mohan PS; Shea TB; Beermann M
Ann N Y Acad Sci; 1994 Dec; 747():77-91. PubMed ID: 7847693
[TBL] [Abstract][Full Text] [Related]
3. Hydrolytic and autolytic behavior of two forms of calcium-activated neutral protease (CANP).
Inomata M; Hayashi M; Nakamura M; Imahori K; Kawashima S
J Biochem; 1985 Aug; 98(2):407-16. PubMed ID: 2999095
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the calcium-activated neutral proteinase (CANP) of bovine brain by myelin lipids.
Chakrabarti AK; Dasgupta S; Banik NL; Hogan EL
Biochim Biophys Acta; 1990 Apr; 1038(2):195-8. PubMed ID: 2331482
[TBL] [Abstract][Full Text] [Related]
5. Multiple calcium-activated neutral proteinases (CANP) in mouse retinal ganglion cell neurons: specificities for endogenous neuronal substrates and comparison to purified brain CANP.
Nixon RA; Quackenbush R; Vitto A
J Neurosci; 1986 May; 6(5):1252-63. PubMed ID: 3012011
[TBL] [Abstract][Full Text] [Related]
6. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
7. Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activities in neurons.
Nixon RA
J Neurosci; 1986 May; 6(5):1264-71. PubMed ID: 3012012
[TBL] [Abstract][Full Text] [Related]
8. Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease.
Inomata M; Hayashi M; Nakamura M; Saito Y; Kawashima S
J Biol Chem; 1989 Nov; 264(31):18838-43. PubMed ID: 2553723
[TBL] [Abstract][Full Text] [Related]
9. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis.
Nixon RA
Ann N Y Acad Sci; 1989; 568():198-208. PubMed ID: 2560900
[TBL] [Abstract][Full Text] [Related]
10. Critical role of calpain in spinal cord degeneration in Parkinson's disease.
Samantaray S; Knaryan VH; Shields DC; Banik NL
J Neurochem; 2013 Dec; 127(6):880-90. PubMed ID: 23875735
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic modification of calcium-dependent protease 1 in erythrocytes treated with ionomycin and calcium.
Croall DE
Biochemistry; 1989 Aug; 28(17):6882-8. PubMed ID: 2554956
[TBL] [Abstract][Full Text] [Related]
12. Autolysis of calcium-activated neutral protease of chicken skeletal muscle.
Suzuki K; Tsuji S; Ishiura S; Kimura Y; Kubota S; Imahori K
J Biochem; 1981 Dec; 90(6):1787-93. PubMed ID: 6277879
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution of calcium-activated neutral proteinases in rat.
Kawashima S; Hayashi M; Saito Y; Kasai Y; Imahori K
Biochim Biophys Acta; 1988 May; 965(2-3):130-5. PubMed ID: 2835111
[TBL] [Abstract][Full Text] [Related]
14. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain.
Sorbi S; Bird ED; Blass JP
Ann Neurol; 1983 Jan; 13(1):72-8. PubMed ID: 6219611
[TBL] [Abstract][Full Text] [Related]
15. Erythrocytic calpain-calpastatin system in Alzheimer's disease.
Soldati L; Alberoni M; Bianchi G; Canal N; Franceschi M
Aging (Milano); 1996 Apr; 8(2):106-8. PubMed ID: 8737608
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of PEBP as a calpain substrate.
Chen Q; Wang S; Thompson SN; Hall ED; Guttmann RP
J Neurochem; 2006 Nov; 99(4):1133-41. PubMed ID: 17018026
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus.
Fukuda T; Adachi E; Kawashima S; Yoshiya I; Hashimoto PH
J Comp Neurol; 1990 Dec; 302(1):100-9. PubMed ID: 2086609
[TBL] [Abstract][Full Text] [Related]
18. Calcium-activated neutral proteinase (CANP; calpain) activity in Schwann cells: immunofluorescence localization and compartmentation of mu- and mCANP.
Banik NL; DeVries GH; Neuberger T; Russell T; Chakrabarti AK; Hogan EL
J Neurosci Res; 1991 Jul; 29(3):346-54. PubMed ID: 1656060
[TBL] [Abstract][Full Text] [Related]
19. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain.
Liu F; Grundke-Iqbal I; Iqbal K; Oda Y; Tomizawa K; Gong CX
J Biol Chem; 2005 Nov; 280(45):37755-62. PubMed ID: 16150694
[TBL] [Abstract][Full Text] [Related]
20. Calcium-activated neutral proteinase of human brain: subunit structure and enzymatic properties of multiple molecular forms.
Vitto A; Nixon RA
J Neurochem; 1986 Oct; 47(4):1039-51. PubMed ID: 3018155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
